Home
About
Overview
Sharing Data
ORCID
Help
History (43)
Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia.
Dorsal root ganglion neurons express multiple nicotinic acetylcholine receptor subtypes.
Inotuzumab Ozogamicin for Relapsed/Refractory Acute Lymphoblastic Leukemia in the INO-VATE Trial: CD22 Pharmacodynamics, Efficacy, and Safety by Baseline CD22.
Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia.
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.
See All 43 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet. 2019 02; 51(2):296-307.
View in:
PubMed
subject areas
Acute Disease
Adolescent
Adult
Aged
Animals
Child
Child, Preschool
Chromosomes
Female
Gene Rearrangement
Humans
Infant
Male
Mice
Mice, Inbred C57BL
Middle Aged
Mutation
PAX5 Transcription Factor
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Transcriptome
Young Adult
authors with profiles
Wendy Stock